5th -
6th
March 2025
March 2025 | 
Stockholm, Sweden

The Foremost Biologics Gathering Dedicated to R&D and Manufacturing in the Nordic Region

5th -
6th
March 2025 | 
Stockholm, Sweden
📆 Add to Google Calendar
Attendees
0 +
Companies
0 +
Speakers
0 +
In-Person Networking Hours
0 +
Case Studies
0 +

Biologics World Nordics 2025 is set to convene biologic and biosimilar developers, manufacturers, technology providers, CMOs, and CROs from the Nordic region and beyond. This premier event serves as a platform to explore partnership and technical collaboration opportunities, discuss best practices in R&D and biomanufacturing, and deliberate growth strategies as Nordic-developed biologics progress through critical clinical phases II and III. As the sole biologics marketplace in the Nordic region, the event showcases the region's vast potential and offers a comprehensive network for Nordic biologic firms seeking to license/partner with large pharmaceutical companies, CROs, and CDMO/CMOs.

FEATURED CONTENT

Biologics Unveiled
[Exploring Growth Prospects] Biologics Unveiled: Mapping the Nordic Innovation Pipeline
BWN23_Nordics-Biopharma-Distribution-Infographics.1-2000x2000
Nordics Biopharma Distribution
3 Reasons why you should expand to nordics
3 Reasons Why You Should Expand to the Nordics!
Why expand to Nordics
Why Expand to Nordics
BWN-23_Firechat-cover-banner-1-1024x576
[Fireside chat] Unlocking the Potential of Biologics in the Nordics: Clinical Trials, Commercialisation, and Emerging Technologies
Biologics World Nordics 2025
  • Leadership Panel Discussion: Current and Future State of the Nordic Biologics Market: Challenges, Opportunities, and Innovation 
  • Driving Innovation in the Nordic Biologics Sector: Leveraging Advanced Technologies and Partnerships for Market Leadership 
  • Application of High-Throughput Screening Technologies in Early-Stage Biologics Discovery 
  • Optimizing Protein Expression Systems for Early-Stage Biologics Discovery: Challenges and Solutions 
  • Advancements in CRISPR-Cas9 Technology for Targeted Gene Editing: Applications and Challenges 
  • Harnessing Advances in Synthetic Biology for Enhanced Gene Therapy Vectors
  • Leveraging Adaptive Trial Designs to Accelerate Drug Development 
  • Incorporating Digital Health Technologies to Optimize Clinical Trials 
  • Fireside Chat: Navigating the Challenges of Global Clinical Trials: Insights from Trial Sponsors and Regulators 
  • Enhancing Cell Culture Efficiency: Overcoming the Challenge of High-Density Fed-Batch Cultures 
  • Adaptive Clinical Trial Design: Accelerating Drug Development with Real-Time Decision-Making 
  • Panel Discussion: Optimizing Quality Control in Nordic Biomanufacturing: Overcoming Analytical Challenges in High-Throughput GMP Environments 
  • Implementing Advanced PAT (Process Analytical Technology) in GMP Manufacturing: Enhancing Real-Time Monitoring and Control for Quality Assurance 
  • Fireside Chat: The Future of Autonomous Biomanufacturing: Can Nordic Biopharma Lead the Next Revolution? 
  • Advanced Sensor Technologies for Real-Time Monitoring and Control in Nordic Bioprocessing Facilities 
  • Digitalizing Cold Chain Management: Enhancing Real-Time Visibility in Biologics Logistics 
  • Cold Chain Management Innovations: Ensuring Temperature Control and Product Integrity in Biologics Distribution 
  • Sustainable and Cost-Efficient Supply Chain Strategies in Biologics Manufacturing 

THANK YOU TO OUR SUPPORTING PARTNERS









Elevate your brand by sponsoring Biologics World Nordics 2025, the premier gathering for biologic and biosimilar stakeholders in the Nordic region. Connect with industry leaders, showcase your expertise, and shape the future of biologics development and manufacturing. Don't miss this opportunity to stand out in the dynamic biologics market.

2025

SPEAKERS

Featuring esteemed voices from the biopharmaceutical sector. Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders. Don't miss this chance to broaden your understanding of this ever-evolving industry.

Andreas Busch

Chief Operations Officer

Eleva

Anna Frostegård

Chief Scientific and Medical Officer

Annexin Pharmaceuticals
Sweden

Christine Lagerquist Hägglund

Vice President CMC Development

Scandinavian Biopharma
Sweden

Christine Lagerquist Hägglund

Vice President CMC Development

Scandinavian Biopharma
Sweden

Dainius Guzauskas

Senior CMC / Regulatory Manager

InflaRx
Germany

David Vikstrom

CTO

Xbrane Biopharma
Sweden

Emanuele Celauro

Senior Research Scientist

AstraZeneca
Sweden

Emma Gyllenplam

Clinical Operations Manager

ILYA Pharma
Sweden

Frank Rauschen

Executive Director Global Strategy Biologics and Cell and Gene Therapy

Novartis
Switzerland

Guro Gafvelin

Chief Technology Officer

Neogap Therapeutics AB
Sweden

Jan Talts

COO,

Amniotics
Sweden

Justyna Anna Leja-Jarblad

Head of Clinical Development

Lokon Pharma
Sweden

Kumar Ashesh

CEO

Paras Biopharma
Finland

Lindsay Davies

Chief Technology Officer

NextCell Pharma
Sweden

Lucienne Vonk

Chief Scientific Officer

Xintela AB
Sweden

Mats Lundgren

Vice President Research and Development

Abera Bioscience
Sweden

Niklas Jungnelius

Process Modeling Leader

Cytiva
Sweden

Sebastian Bauer

CMC Director

Combigene
Sweden

Teit Max Moscote Søgaard

Senior Vice President R&D and Technology

ExpreS2ion Biotechnologies
Denmark

APPLY FOR A SPEAKING OPPORTUNITY

Calling all scientific pioneers and industry leaders! Join us at Biologics World Nordics 2025 as we seek dynamic speakers to share groundbreaking research, innovative strategies, and scientific insights shaping the future of biologics development in the Nordic region. Showcase your expertise and contribute to advancing the frontier of biopharmaceuticals at this premier event.

DELEGATE REGISTRATION

Local Biopharmas, Academics & Research Institutes
From £ 1050

Early Bird (valid until 22 November 2024) 
£1050.00 ex VAT 

Standard Rate (valid from 23 November - 21 February 2025) 
£1250.00 ex VAT 

Final Call (valid from 22 February 2025 - 5 March 2025) 
£1450.00 ex VAT 

*Local Biopharma and Academia pricing is intended for Biopharma companies headquartered in the Nordics, as well as for Academic and Research Institutes

**Value Added Tax (VAT) exemptions will be applied where applicable in accordance with relevant regulations
International Biopharma
From £1350

Early Bird (valid until 22 November 2024) 
£1350.00 ex VAT 

Standard Rate(valid from 23 November - 21 February 2025) 
£1550.00 ex VAT 

Final Call (valid from 22 February 2025 - 5 March 2025) 
£1750.00 ex VAT 

*International Biopharma pricing is intended for Biopharmas headquartered outside the Nordics

**Value Added Tax (VAT) exemptions will be applied where applicable in accordance with relevant regulations
Big Pharma
From £2250

Early Bird (valid until 22 November 2024)  
£2250.0 ex VAT 

Standard (valid from 23 November - 21 February 2025) 
£2450.00 ex VAT 

Final Call (valid from 22 February 2025 - 5 March 2025) 
£2650.00 ex VAT 

*Big Pharma Pricing is intended for global pharmaceutical companies focused on drug development, research, and healthcare solutions

**Value Added Tax (VAT) exemptions will be applied where applicable in accordance with relevant regulations
Technology, Service, & Solution Providers
View the Prospectus

Biologics World Nordics is not limited only to biopharma and big pharma; representatives of service, solution, and technology providers are welcome to attend. 

Reach out today and download the prospectus for detailed information on attendee options, sponsorship opportunities and benefits, and how to maximise your presence at #BWN2025

Get in touch by e-mail: [email protected]

DELEGATE REGISTRATION

Catch the limited super access in time to save BIG!

Local Biopharmas, Academics & Research Institutes
From £ 1050

Early Bird (valid until 22 November 2024) 
£1050.00 ex VAT 

Standard Rate (valid from 23 November - 21 February 2025) 
£1250.00 ex VAT 

Final Call (valid from 22 February 2025 - 5 March 2025) 
£1450.00 ex VAT 

*Local Biopharma and Academia pricing is intended for Biopharma companies headquartered in the Nordics, as well as for Academic and Research Institutes

**Value Added Tax (VAT) exemptions will be applied where applicable in accordance with relevant regulations
International Biopharma
From £1350

Early Bird (valid until 22 November 2024) 
£1350.00 ex VAT 

Standard Rate(valid from 23 November - 21 February 2025) 
£1550.00 ex VAT 

Final Call (valid from 22 February 2025 - 5 March 2025) 
£1750.00 ex VAT 

*International Biopharma pricing is intended for Biopharmas headquartered outside the Nordics

**Value Added Tax (VAT) exemptions will be applied where applicable in accordance with relevant regulations
Big Pharma
From £2250

Early Bird (valid until 22 November 2024)  
£2250.0 ex VAT 

Standard (valid from 23 November - 21 February 2025) 
£2450.00 ex VAT 

Final Call (valid from 22 February 2025 - 5 March 2025) 
£2650.00 ex VAT 

*Big Pharma Pricing is intended for global pharmaceutical companies focused on drug development, research, and healthcare solutions

**Value Added Tax (VAT) exemptions will be applied where applicable in accordance with relevant regulations
Technology, Service, & Solution Providers
View the Prospectus

Biologics World Nordics is not limited only to biopharma and big pharma; representatives of service, solution, and technology providers are welcome to attend. 

Reach out today and download the prospectus for detailed information on attendee options, sponsorship opportunities and benefits, and how to maximise your presence at #BWN2025

Get in touch by e-mail: [email protected]

Online Survey

FEATURED CONTENT

Biologics Unveiled
[Exploring Growth Prospects] Biologics Unveiled: Mapping the Nordic Innovation Pipeline
BWN23_Nordics-Biopharma-Distribution-Infographics.1-2000x2000
Nordics Biopharma Distribution
3 Reasons why you should expand to nordics
3 Reasons Why You Should Expand to the Nordics!
Why expand to Nordics
Why Expand to Nordics
BWN-23_Firechat-cover-banner-1-1024x576
[Fireside chat] Unlocking the Potential of Biologics in the Nordics: Clinical Trials, Commercialisation, and Emerging Technologies

Don't Just Take Our Word For It

HEAR FROM OUR CLIENTS

This conference was long overdue in Singapore and critical to making sure that CCT understands current challenges facing our Asian based clients. This allows us to quickly provide new or turn-key solutions and products that meet their needs.

CCO,  
Regional Commercial Director  

Cold Chain Technologies

BMA was an excellently organised event and as a sponsor, participating was very valuable in meeting new connections and engaging with existing customers & contacts. I would recommend anyone involved in the regional biologics industry to participate in the event.

Ciaran O'Keeffe,  
Director Business Development & Channel Sales  

MasterControl

With the many restrictions and the need to hold the event onsite and online, I do think this event is well planned and held. Easy registration. Spacious, simple and professional settings. All the staffs are very friendly and helpful too. Thank you!

Senior,  
Technical Account Specialist  

West Pharmaceutical Services

Bioworkshops appreciate the effort IMAPAC invested to restore a strong In-person participation to this hybrid event, bringing together many of the biologics manufacturing leaders from Asia along and global experts.

Nick Kotlarski,  
President, VP of BioManufacturing  

Bioworkshops Limited

The conference was a great success and fruitful.

Cai Bao,  
VP of BioManufacturing  

Biocon

Fantastic conference with professional team.

Julio Lin,  
VP  

Blue Blood Biotech

Informative session. Exhibition was well targeted and diverse. Presenters shared latest development

Sankar Dharmaraj,  
Head, GMP Operations  

Hilman Laboratories

It was an awesome experience to interact with so many energetic young professionals around the globe and share technical information. I want to express my heartfelt gratitude to the organizer for such a great event!

MD Atiqur Rahman,  
Senior Executive Officer, Professional (Sterile)  

Incepta

It was great to attend the session physically, and have some exchange with industry players and exchange ideas. Thanks IMAPAC for great organisation!

Koh Wei Jet,  
Sanofi  

EVF Project Process Manufacturing Leader

Great forum for face to face interactions and for exchange of ideas and information.

Chris Lee,  
Site head, Singapore Development and Manufacturing  

WuXi Biologics

The entire event was managed flawlessly by the Organizers. I personally did not face any technical glitches despite this even was organized in a hybrid manner. Almost every speaker gave a high quality presentation which was very insightful.

Chandrakant Kathote,  
Site Head & Vice President  

Lupin Ltd

It was really great experience for me to be associated with IMAPAC which organizes high standard conference. Speakers from various domains/fields are thoughtfully chosen & they have delivered the relevant fields of present post-covid pandemic biologics scenario.

Dr. Swapan Kumar Jana,  
Director R&D and Manufacturing  

Serum Institute Of India Pvt. Limited

A well organized ambitious meeting. I hope it will continue to develop in the future.

Jean Francois Dierick,  
Strategic Analytical Validation and Lifecycle Lead, Analytical Research and Development  

GSK Vaccines

#BUZZ ABOUT THE EVENT

SIMILAR EVENTS

Register Now. SAVE BIG!

Download Post Event Report Form

Download Participating Companies

IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.

Download Attendee List

Download Prospectus Document Form

Brochure Form

Sponsorship Form

IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.

Download Agenda Form

Apply For Speaking Opportunity

Featured Content Form

Download List of Biopharma Companies in Asia Brochure

Download Ebook

Download Ebook

VWSEA2024 Brochure

Download List of Biopharma, CMO, CRO, CDMO and Big Pharma in China and Taiwan Brochure

Download Strategic Consulting Brochure

Download Case Study Consulting Digital Disruption

Download Case Study Consulting Revolutionizing Biopharmaceuticals

Download IMAPAC Custom Events Prospectus

Download Case Study : Fill-Finish Solution provider increasing its market share

Download Case Study : European CMO expanding into APAC

Download Case Study : China CDMO's New Gene Protein Facility Opening

Download Biologics Newsletter

Download Cell and Gene Therapy Newsletter

Download Vaccines Newsletter

Download 1:1 Networking Meetings Case Study- High-end assembly solutions provider

Download 1:1 Networking Meetings Case Study- IT/Software Solution provider

Download 1:1 Networking Meetings Case Study

Download Ebook

Download Ebook

Download Events Calendar

Customised Webinar/Webcast

Download Customised Events Brochure

Contact us for Third Party Email Services

Download Newsletter Press Kit

Download Network Meetings Prospectus

Download Media Kit

Download Form

Cell and Gene Therapy World Summit Brochure

    Contact Form


    IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.

    Download Brochure Sample

      Contact Form


      IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.